Skip to main content

What We Do

MTRC has been providing reimbursement, health economic and evidence synthesis services to the medical device and in-vitro diagnostics industry in Europe since 2017. 

Coding, payment mechanism, reimbursement tariffs, the pathway to create or improve reimbursement situation for the technology 

Experience in 34 EU countries, Australia and Canada

Adaptations of global models to EU countries and development of de novo models

Early and full value dossiers for the med tech industry, systematic literature reviews and meta-analyses

General introductory seminars and more than 70 country-specific seminars

Subscription service with email alerts about initiated or published health technology assessments and reimbursement decisions for medical devices and IVD tests from reimbursement (EU) and HTA (global) organizations

News and insights

To stay up to date, we constantly monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get bi-weekly updates key reimbursement/HTA news items

Subscribe Subscribe Subscribe Subscribe Subscribe Subscribe

Our free newsletter contains less than 10% of the identified news items. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to access full, customised reports from more than 90 reimbursement and HTA organizations globally

03 Oct 2023

Med Tech-related technology assessments and clinical guidelines from NICE in September 2023

In September 2023, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (removal, preservation, and reimplantation of ovarian tissue for restoring fertility, transurethral water-jet ablation for lower urinary tract symptoms, cryotherapy for chronic rhinitis), and three Health Technology Evaluations using early value assessment (AI-derived software to analyze chest X-rays for suspected lung cancer, AI technologies to aid contouring for radiotherapy planning, KardiaMobile 6L for adults having antipsychotic medication). Also, two new clinical guidelines were published, and three were updated.
02 Oct 2023

Call for input regarding MRgFUS for the “New Methods” framework in Norway

The “New Methods” framework invited interested parties to submit information regarding magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) for treating intracranial tumors, neurodegenerative disease, and pain related to bone metastases before October 31, 2023. Ordering Forum will then decide whether the method will undergo evaluation at the national level.
29 Sep 2023

Blog: Project ideas: What HEOR projects are requested by our clients? Part 3

Market access is a challenging field. Multiple priorities have to be managed within a limited budget. We would like to share the anonymized outlines of the projects in the HEOR and market access fields commissioned to MTRC to inspire our clients. The next example is the rapid development of value messages to support positioning and marketing activities.

Geography of our projects

MTRC is a provider of multi-country European projects. We have worked on the projects in 34 European countries

MTRC in numbers 

An extremely specialised boutique consultancy with a global impact

Full-time employees
Regular clients from the top 30 med tech companies
Of business comes from Small to Medium-sized Enterprises (SMEs)

Why partner with MTRC?

Be confident in the results

We are accredited by the United Kingdom Accreditation Service (UKAS) as an ISO 9001:2015 certified vendor, specialised in medical technologies market access. Unlike many of our competitors, we dedicate 100% of our time and focus to the area of medical technologies, so that our clients enjoy higher quality services at a lower cost

Avoid the hassle of working with multiple vendors

We specialize in Pan-European projects and worked in 34 countries in Europe. You can save time, effort and money by working with a single experienced vendor vs contracting several consultants individually

Spend less on consulting

We understand the budgetary challenges of the med tech industry and can therefore offer a cost-effective approach to our specialised services. Thirty-six percent (36%) of our current business comes from small to medium-sized enterprises (SMEs) – a testament to our unique and personal approach to solve your budgetary challenges

Direct access to senior leadership

Small enough to ensure significant personal attention, and large enough to address your needs, our boutique consultancy guarantees that each project enjoys the attention it deserves with direct access to our senior leaders

Make decisions and advance your business quickly

We appreciate the time-sensitive nature of market access. Being a flexible team, we are not afraid to go beyond regular working hours to meet the high expectations of our clients. For every type of project, we offer the shortest possible turnaround times

Technological coverage of our services

We provide services for major types of medical technologies:

Implantable devices
Interventional procedures
Non-interventional procedures
In-Vitro diagnostics (IVD) tests
Medical aids

Our team has worked on hundreds of reimbursement/HEOR projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, and endoscopy, amongst others.

Thought Leadership

Paid subscription service Health Technology Assessment (HTA) Alerts

Subscription service with email alerts about initiated, published and ongoing health technology assessments of medical technologies from 68 HTA organizations globally. Learn more and request free, no-obligation three-month trial.

Learn more

Paid subscription service Reimbursement Alerts

Subscription service with email alerts about key reimbursement developments for medical technologies from 46 organisations in 15 European countries. Learn more and request a free, no-obligation three-month trial.

Learn more

Free EU reimbursement news and Publications Digest

Bi-weekly newsletter with 10 key reimbursement/HTA news items and summaries of the most important peer-reviewed publications. Access news from as far back as 2017. 

Learn more

Syndicated reports

Since 2017, MTRC has developed syndicated reports on innovative payment schemes, HTA activities in the med tech field, and reimbursement of digital technologies amongst others. See the content and download sample pages.

Learn more

Report on innovative payment schemes for EU association Med Tech Europe

In 2022 Med Tech Europe and MTRC developed a comprehensive report on innovative payment schemes in European countries.

Learn more


MTRC offers several free webinars on the topic of med tech market access.

Learn more

Educational materials on market access

MTRC offers the most comprehensive repository of training presentations on the topic of med tech market access. We offer both general introductory seminars (including pre-recorded webinars) and more than 70 country-specific seminars. 

Learn more

Youtube channel “Market Access Insider”

In 2019 MTRC launched a channel dedicated to the topic of market access for medical devices. See our interviews with different stakeholders from EU countries.

Learn more

Get in touch

Contact us to discuss your needs and learn about our services